Lanean...
The Risk Factors for the Wearing-Off Phenomenon in Parkinson's Disease
Introduction: First-line treatment of Parkinson's disease (PD) includes a dopamine analog, levodopa, administered in combination with carbidopa to increase efficacy. Wearing-off (WO) phenomenon is a frequent complication which is defined as a reoccurrence of motor and non-motor symptoms during...
Gorde:
| Argitaratua izan da: | Cureus |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Cureus
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7599057/ https://ncbi.nlm.nih.gov/pubmed/33145134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10729 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|